Cargando…
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
Recent years have seen the establishment of several radionuclides as medicinal products in particular in the setting of theranostics and PET. [(177)Lu]Lutetium Chloride or [(64)Cu]Copper Chloride have received marketing authorization as radionuclide precursor, [(68)Ga]Gallium Chloride has received r...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192700/ https://www.ncbi.nlm.nih.gov/pubmed/34124109 http://dx.doi.org/10.3389/fmed.2021.678452 |